144: Filer Information
Filer CIK | 0001895592 |
Filer CCC | XXXXXXXX |
Is this a LIVE or TEST Filing? | LIVE TEST |
Submission Contact Information | |
Name | |
Phone | |
E-Mail Address |
Form 144 Filer Information |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 | |
FORM 144 |
Filer CIK | 0001895592 |
Filer CCC | XXXXXXXX |
Is this a LIVE or TEST Filing? | LIVE TEST |
Submission Contact Information | |
Name | |
Phone | |
E-Mail Address |
Name of Issuer | Alector, Inc. |
SEC File Number | 001-38792 |
Address of Issuer | 131 Oyster Point Blvd. Suite 600 South San Francisco CALIFORNIA 94080 |
Phone | (415)-231-5660 |
Name of Person for Whose Account the Securities are To Be Sold | Sara Kenkare-Mitra |
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account
the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given
as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales
for the account of the person filing this notice.
| |
Relationship to Issuer | Officer |
Title of the Class of Securities To Be Sold | Name and Address of the Broker | Number of Shares or Other Units To Be Sold | Aggregate Market Value | Number of Shares or Other Units Outstanding | Approximate Date of Sale | Name the Securities Exchange |
---|---|---|---|---|---|---|
Common Stock | E*TRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005 | 3956 | 27019 | 83351778 | 06/02/2023 | Nasdaq |
Title of the Class | Date you Acquired | Nature of Acquisition Transaction | Name of Person from Whom Acquired | Is this a Gift? | Date Donor Acquired | Amount of Securities Acquired | Date of Payment | Nature of Payment * |
---|---|---|---|---|---|---|---|---|
Common Stock | 06/01/2023 | Vesting of Restricted Stock Units | Issuer | 11614 | 06/01/2023 | (1) |
Name and Address of Seller | Title of Securities Sold | Date of Sale | Amount of Securities Sold | Gross Proceeds |
---|---|---|---|---|
Sara Kenkare-Mitra C/O Alector, Inc. 131 Oyster Point Blvd., Suite 600 South San Francisco CA 94080 | Common Stock | 03/02/2023 | 10124 | 84216 |
Remarks | (1) The securities to be sold were received upon the settlement of vested restricted stock units. |
Date of Notice | 06/01/2023 |
ATTENTION: | |
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date. | |
Signature | /s/ Jordan Hochstrasser, by power of attorney |
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001) |
Exhibit 24
POWER OF ATTORNEY
The undersigned reporting person of Alector, Inc., (the “Company”) hereby constitutes and appoints Arnon Rosenthal, Marc Grasso, Cameron Hagen and Jordan Hochstrasser, and each of them, the undersigned’s true and lawful attorney-in-fact to:
1. complete and execute Form 144, Notice of Proposed Sale of Securities, and any other required form, and all amendments to such forms, as such attorney-in-fact shall in his or her discretion determine to be required or advisable pursuant to the Securities Exchange Act of 1933 and the rules and regulations thereunder, or any successor laws and regulations, as a consequence of the undersigned’s disposition of securities of the Company; and
2. do all acts necessary in order to file such forms with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the attorneys-in-fact shall deem appropriate.
The undersigned hereby ratifies and confirms all that said attorneys‑in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Rule 144 of the Securities Exchange Act of 1933 (as amended).
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Form 144 with respect to the undersigned’s disposition of securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 30th day of May, 2023.
Signature: /s/ Sara Kenkare-Mitra
Print Name: Sara Kenkare-Mitra